Cite
APA Citation
Codreanu, C., Šírová, K., Jarošová, K., & Batalov, A. (2018). assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis. Current medical research and opinion, 34, 1763–1769. http://access.bl.uk/ark:/81055/vdc_100068018945.0x000042